Quest Diagnostics Gross Margin 2010-2024 | DGX

Current and historical gross margin for Quest Diagnostics (DGX) over the last 10 years. The current gross profit margin for Quest Diagnostics as of March 31, 2024 is %.
Quest Diagnostics Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-03-31 $9.29B $3.05B 32.87%
2023-12-31 $9.25B $3.05B 33.00%
2023-09-30 $9.30B $3.08B 33.08%
2023-06-30 $9.49B $3.19B 33.61%
2023-03-31 $9.60B $3.24B 33.73%
2022-12-31 $9.88B $3.43B 34.74%
2022-09-30 $10.29B $3.70B 35.95%
2022-06-30 $10.58B $3.94B 37.20%
2022-03-31 $10.68B $4.08B 38.21%
2021-12-31 $10.79B $4.21B 39.02%
2021-09-30 $11.05B $4.45B 40.30%
2021-06-30 $11.06B $4.55B 41.18%
2021-03-31 $10.34B $4.18B 40.40%
2020-12-31 $9.44B $3.63B 38.50%
2020-09-30 $8.36B $3.03B 36.19%
2020-06-30 $7.53B $2.51B 33.36%
2020-03-31 $7.66B $2.59B 33.88%
2019-12-31 $7.73B $2.69B 34.80%
2019-09-30 $7.64B $2.63B 34.44%
2019-06-30 $7.57B $2.61B 34.42%
2019-03-31 $7.54B $2.59B 34.41%
2018-12-31 $7.53B $2.61B 34.59%
2018-09-30 $7.56B $2.67B 35.36%
2018-06-30 $7.52B $2.67B 35.50%
2018-03-31 $7.47B $2.69B 36.00%
2017-12-31 $7.40B $2.68B 36.25%
2017-09-30 $7.10B $2.41B 33.99%
2017-06-30 $7.13B $2.47B 34.72%
2017-03-31 $7.17B $2.53B 35.31%
2016-12-31 $7.21B $2.60B 36.01%
2016-09-30 $7.50B $2.90B 38.61%
2016-06-30 $7.50B $2.89B 38.50%
2016-03-31 $7.52B $2.88B 38.30%
2015-12-31 $7.49B $2.84B 37.85%
2015-09-30 $7.53B $2.84B 37.68%
2015-06-30 $7.55B $2.84B 37.66%
2015-03-31 $7.53B $2.83B 37.58%
2014-12-31 $7.44B $2.80B 37.63%
2014-09-30 $7.31B $2.80B 38.37%
2014-06-30 $7.19B $2.78B 38.61%
2014-03-31 $7.11B $2.77B 38.99%
2013-12-31 $7.15B $2.82B 39.46%
2013-09-30 $7.16B $2.82B 39.31%
2013-06-30 $7.20B $2.86B 39.71%
2013-03-31 $7.26B $2.91B 40.12%
2012-12-31 $7.38B $3.02B 40.88%
2012-09-30 $7.37B $3.03B 41.15%
2012-06-30 $7.45B $3.08B 41.35%
2012-03-31 $7.48B $3.11B 41.52%
2011-12-31 $7.39B $3.03B 40.99%
2011-09-30 $7.35B $2.99B 40.72%
2011-06-30 $7.31B $2.97B 40.71%
2011-03-31 $7.28B $2.97B 40.83%
2010-12-31 $7.26B $2.99B 41.11%
2010-09-30 $7.39B $3.09B 41.74%
2010-06-30 $7.43B $3.11B 41.92%
2010-03-31 $7.45B $3.12B 41.85%
2009-12-31 $7.46B $3.14B 42.05%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.369B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.408B 11.14
DaVita (DVA) United States $12.274B 15.25
Encompass Health (EHC) United States $8.690B 22.25
Chemed (CHE) United States $8.208B 25.44
Elanco Animal Health (ELAN) United States $6.326B 16.41
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.626B 96.34
Amedisys (AMED) United States $3.184B 22.56
Astrana Health (ASTH) United States $2.784B 37.66
Addus HomeCare (ADUS) United States $2.196B 28.43
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.448B 38.74
Pennant (PNTG) United States $0.836B 44.19
Aveanna Healthcare Holdings (AVAH) United States $0.770B 0.00
Atai Life Sciences (ATAI) Germany $0.249B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.018B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00